(4S)-4-(2-CYCLOPROPYLETHYNYL)-5-FLUORO-3,4-DIHYDRO-6-HYDROXY-4-(TRIFLUOROMETHYL)-2(1H)-QUINAZOLINONE
UNII RZV16A9OON
Substance Identification & Data
This profile provides standardized clinical and technical data for (4s)-4-(2-cyclopropylethynyl)-5-fluoro-3,4-dihydro-6-hydroxy-4-(trifluoromethyl)-2(1h)-quinazolinone, uniquely identified by the FDA Unique Ingredient Identifier (UNII) RZV16A9OON.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 410090-45-8 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C14H10F4N2O2 VFPCFVHIAAPSCF-ZDUSSCGKSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for (4s)-4-(2-cyclopropylethynyl)-5-fluoro-3,4-dihydro-6-hydroxy-4-(trifluoromethyl)-2(1h)-quinazolinone. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.